Tell that to the 3,000 doctors and tens of thousand of patients that have used QCOR's drug when other protocols have failed them! I know Citron will start to say its a placebo effect only! Bottom line is the stock has climbed from under $5 a share at the end of 2009 to more than $80 a share recently with a strong reputable institutional following. We will continue to climb higher over the next 12 - 36 months in spite of the shorts trying to hold the price down. Slow and steady! Good luck to all!